Amphetamine Toxicity Treatment & Management
- Author: Neal Handly, MD, MS, MSc; Chief Editor: Asim Tarabar, MD more...
Prehospital Care
Prehospital care of patients with amphetamine intoxication often requires physical and chemical restraint of the patient and treatment of complications of intoxication, including seizures, loss of competent airway, cardiac dysrhythmias, and trauma.
Emergency Department Care
- Patients with amphetamine intoxication who present with no life-threatening signs or symptoms may be treated with sedation and observation.
- Complications may require the physician to perform procedures to establish airway management or fluid resuscitation or to initiate vigorous cooling measures.
- In patients with acute oral ingestion, GI decontamination is performed by the administration of activated charcoal. Orogastric lavage often is not necessary but may be performed when the patient presents with immediately life-threatening intoxication shortly after ingestion. Whole-bowel irrigation may be indicated in suspected cases of body stuffing or body packing (large quantities of drugs in wrapping for international transport or drug hiding, respectively).
- Foley catheter placement may be useful to monitor urine output, particularly in situations in which diuretics are administered to manage pulmonary edema. Patients often have decreased urination due to the effects on bladder sphincter muscles to prevent passing urine. Other individuals may be dehydrated after recreational use in raves and club events. Quick assessment of bladder fullness can be performed with bedside ultrasonography or bladder palpation.
- Agitation or persisting seizures in patients with amphetamine toxicity requires generous titration of benzodiazepines and a calm soothing environment. Avoid physical restraints, if possible.
- Significant cardiac dysrhythmias may require cardioversion, defibrillation, and antidysrhythmics.
- Use benzodiazepine sedation (nonspecific sympatholysis) to initially manage hypertension, if present. Refractory cases or cases associated with significant end-organ toxicity (eg, cardiovascular accident [CVA], myocardial ischemia) can be managed with intravenous phentolamine, nitroprusside, or nitroglycerin.
- Avoid use of beta-blockers in order to prevent unopposed alpha effect (vasoconstriction).
- Cardiogenic pulmonary edema can be managed with nitroglycerin and diuretics.
- Aggressively cool hyperthermic patients with evaporative cooling, ice packs to the groin and axilla, and use of "ice-bath" (total body immersion in ice). Patients with severe hyperthermia (temperature >104°F) associated with psychomotor agitation may require immediate neuromuscular paralysis to rapidly decrease temperature. Temperature control should be achieved within 15-20 minutes upon presentation in order to prevent multiorgan failure and death.
- Haloperidol is controversial[19] in the treatment of agitation in any patient with the potential to seize or develop hyperthermia because of associations with lowering the seizure threshold and altering thermoregulation.
- Of all neuroleptic drugs, however, haloperidol rarely is associated with seizures (minimal effects on seizure threshold). In addition, animal studies suggest that haloperidol can antagonize amphetamine-induced hyperthermia. Haloperidol can be considered as an adjunct to benzodiazepines for afebrile patients with normal vital signs and psychomotor agitation that requires chemical restraint.
- Look for and treat traumatic injuries in patients with amphetamine intoxication.
Consultations
- A medical toxicologist may be consulted for assistance in the management of amphetamine toxicity cases.
- Patients who demonstrate focal neural deficits or have CT scans of the head that indicate bleeding may need neurologic or neurosurgical consultations.
- Patients who show significant cardiac injury may require cardiologic consultation.
White TL, Lott DC, de Wit H. Personality and the subjective effects of acute amphetamine in healthy volunteers. Neuropsychopharmacology. May 2006;31(5):1064-74. [Medline].
Murray JB. Psychophysiological aspects of amphetamine-methamphetamine abuse. J Psychol. Mar 1998;132(2):227-37. [Medline].
Karch S. The problem of methamphetamine toxicity. West J Med. Apr 1999;170(4):232. [Medline].
Downes MA, Whyte IM. Amphetamine-induced movement disorder. Emerg Med Australas. Jun 2005;17(3):277-80. [Medline].
Wappler F, Roewer N, Kochling A, Scholz J, Loscher W, Steinfath M. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients. Anesthesiology. Jun 1996;84(6):1280-7. [Medline].
Richards CF, Clark RF, Holbrook T, Hoyt DB. The effect of cocaine and amphetamines on vital signs in trauma patients. J Emerg Med. Jan-Feb 1995;13(1):59-63. [Medline].
Uvnas-Moberg K, Hillegaart V, Alster P, Ahlenius S. Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat. Neuropharmacology. 1996;35(11):1635-40. [Medline].
Jacobs W. Fatal amphetamine-associated cardiotoxicity and its medicolegal implications. Am J Forensic Med Pathol. Jun 2006;27(2):156-60. [Medline].
Chin KM, Channick RN, Rubin LJ. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?. Chest. Dec 2006;130(6):1657-63. [Medline].
Irvine GD, Chin L. The environmental impact and adverse health effects of the clandestine manufacture of methamphetamine. NIDA Res Monogr. 1991;115:33-46. [Medline].
Röhrich J, Schmidt K, Bratzke H. [Detection of amphetamine derivatives in chemical toxicological studies 1987-1993 in the greater Frankfurt area]. Blutalkohol. Jan 1995;32(1):42-9. [Medline].
Ko YC, Lan SJ, Yen YY, Su IH, Chen BH, Tsai JL. [The prevalence of amphetamine use in adolescent students: self-reported and urine analysis]. Gaoxiong Yi Xue Ke Xue Za Zhi. Nov 1991;7(11):582-9. [Medline].
Alldredge BK, Lowenstein DH, Simon RP. Seizures associated with recreational drug abuse. Neurology. Aug 1989;39(8):1037-9. [Medline].
Westover AN, Nakonezny PA, Haley RW. Acute myocardial infarction in young adults who abuse amphetamines. Drug Alcohol Depend. Jul 1 2008;96(1-2):49-56. [Medline].
Borders TF, Booth BM, Han X, Wright P, Leukefeld C, Falck RS, et al. Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation. Addiction. May 2008;103(5):800-8. [Medline].
Huang B, Dawson DA, Stinson FS, Hasin DS, Ruan WJ, Saha TD, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. Jul 2006;67(7):1062-73. [Medline].
Justice AJ, De Wit H. Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav. Jul 2000;66(3):509-15. [Medline].
Carvalho F, Remiao F, Soares ME, Catarino R, Queiroz G, Bastos ML. d-Amphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effect studied in isolated rat hepatocytes. Arch Toxicol. 1997;71(7):429-36. [Medline].
Derlet RW, Albertson TE, Rice P. The effect of haloperidol in cocaine and amphetamine intoxication. J Emerg Med. Nov-Dec 1989;7(6):633-7. [Medline].
Plessinger MA. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am. Mar 1998;25(1):119-38. [Medline].

